Maxim Group
Maxim Group is a privately held investment bank, broker-dealer and wealth manager headquartered in New York. Its equity research concentrates on small-cap companies across healthcare, technology, financial services and industrials.
Activity24M
RatingsPrice targetsKey figures
- Stocks covered
- 12912M
- Actions
- 19112M
- Ratings / Price targets
- 93 / 98
- Upgrades / Downgrades
- 8 / 24
- Initiations
- 2
- Buy-rated
- 73%of 82 rated
- Median upside
- +98.1%
- Targets raised / lowered
- 22 / 10
- On record
- Apr 2012 – Sep 2026
Overview
Maxim's research team covered about 200 companies as of 2021, with eight senior publishing analysts focused on healthcare, technology, media, financial services and industrials. As of August 2026, 86% of rated stocks were Buy and none were Sell. It aims its reports and conferences at institutional clients and company CEOs and boards; its disclosures show that, as of August 2026, about half of the companies it rated had received its investment banking services in the prior 12 months.
Maxim Group was formed in 2002 through a management buyout, led by Michael Rabinowitz, of core US assets of Investec Ernst & Company, and was set up as an independent, 100% employee-owned firm. Freedom Holding agreed to acquire it in February 2023, but the parties terminated the deal that October. Clifford Teller, head of investment banking from 2002 to 2022, became chairman and chief executive in March 2024.
Milestones
- 2002
Formed via management buyout of Investec Ernst & Company assets
- 2023
Freedom Holding acquisition agreed, then terminated
- 2024
Clifford Teller becomes chairman and chief executive officer
Firm facts
- Legal name
- Maxim Group LLC
- Type
- Boutique
- Founded
- 2002
- Headquarters
- New York, United States
- Chairman and CEO
- Clifford Teller
- Director of Research
- Anthony Vendetti
- Rating scale
- BuyHoldSell12 months
- Website
- maximgrp.com
Research philosophy
Our research is tailored to be actionable and trading-oriented to achieve an alpha goal.
Maxim says its analysts take a fundamental, bottom-up approach to mid-cap, small-cap and emerging growth companies.
Rating methodology
Stocks are rated Buy, Hold or Sell on expected performance against a relevant index over the next 12 months, with a separate Speculative risk rating for early-stage companies. Buy and Sell ratings are tied to fundamental metrics or identifiable catalysts.
Coverage12M
Sectors
Most covered24M
| Stock | Rating | Target |
|---|---|---|
 Apple Inc.AAPL | Buy | $350 |
 Rezolute, Inc.RZLT | Buy | $14 |
 Worksport Ltd.WKSP | Buy | $2 |
 Nicolet Bankshares, Inc.NIC | Buy | $173 |
 Nutex Health, Inc.NUTX | Buy | $205 |
 Enova International, Inc.ENVA | Buy | $200 |
 Imperial Petroleum Inc.IMPP | Buy | $9 |
 BWX Technologies, Inc.BWXT | Hold | $140 |
 Diversified Healthcare TrustDHC | Buy | $10.50 |
 Datavault AI Inc.DVLT | Buy | $4 |
Most active analysts
- Tate Sullivan12 notesWKSPHMRFEAM
- Michael Diana8 notesCFRDHCBEEP
- Jason McCarthy7 notesZVRABNGOCAPR
- Tom Forte7 notesAAPLAMZNRZLV
- Anthony Vendetti6 notesBHSTHLFICU
- Allen Klee6 notesAIREEEXIPM
Recent actions
| Date | Stock | Rating action | Rating | Target | Analyst |
|---|---|---|---|---|---|
| Sep 18 | MRMerlin, Inc.MRLN | Target | $7 | Matthew Galinko | |
| Sep 17 | TETelomir Pharmaceuticals, Inc. Common StockTELO | Target | $4 | ||
| Sep 15 | UCU Power LimitedUCAR | Downgrade | Buy →Hold | ||
| Sep 9 | CCCheche Group Inc.CCG | Downgrade | Buy →Hold | ||
| Aug 31 | FIDeep Fission, Inc.FISN | Target | $17 | ||
| Aug 24 | ICIntchains Group LimitedICG | Reiterate | Buy | $3 | |
| Aug 24 | NXNEXGEL, Inc.NXGL | Downgrade | Buy →Hold | ||
| Aug 20 | NVNvni Group Limited Ordinary SharesNVNI | Downgrade | Buy →Hold | ||
| Aug 19 | DEDeFi Technologies Inc.DEFT | Downgrade | Buy →Hold | ||
| Aug 17 | YCcbdMD, Inc.YCBD | Downgrade | Buy →Hold | ||
| Aug 14 | NMNeuroOne Medical Technologies CorporationNMTC | Target | $3 →$5 |